Porphyridium cruentum: a factory for the production of a new polysaccharide-based biomaterial for tissue regeneration

Marine algae and their metabolites have been widely recognized for their bioactive properties with applications in various industries, such as nutraceutical, cosmetical, and pharmaceutical. In this study, the best strategy for the extraction and processing of the exopolysaccharides (EPS) from Poryphydium cruentum for a laboratory scale was discussed, and the collected, purified EPS fraction was extensively characterized. The results show that impurities and other co-precipitants can be significantly reduced via trichloroacetic acid (TCA) treatment, followed by dialysis, resulting in a more purified EPS fraction with a higher carbohydrate content and solubility ability, at the cost of lower mass yield. The obtained EPS fraction was of a high molecular weight, presented a high crystallinity index, was thermally stable and cytocompatible within the range of tested concentrations. These results show its potential to be used as a new platform for healing and regeneration of chronic wounds.